Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight? Tahir Rahman, MD A form of aripiprazole places unique ethical and clinical demands on mental health professionals. AMA J Ethics. 2019;21(4):E332-336. doi: 10.1001/amajethics.2019.332. Case and Commentary May 2019 How Should Physicians Respond to Requests for LVAD Removal? Larry A. Allen, MD, MHS Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward. AMA J Ethics. 2019;21(5):E394-400. doi: 10.1001/amajethics.2019.394. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 1 Stephen Corey, MD and Peter Bulova, MD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):373-378. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Policy Forum Dec 2019 How Should Gene Editing Be Managed by Risk Managers? David Sine, D.Bioethics Little claims data exists upon which to make informed decisions about loss control or to draw upon when developing risk mitigation strategies. AMA J Ethics. 2019;21(12):E1059-1064. doi: 10.1001/amajethics.2019.1059. Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604. Case and Commentary Sep 2017 What Does Health Justice Look Like for People Returning from Incarceration? Lisa Puglisi, MD, Joseph P. Calderon, CHW, and Emily A. Wang, MD, MAS Equitable transitions of care for incarcerated patients returning to the community will require physician advocacy and systems-level change. AMA J Ethics. 2017;19(9):903-910. doi: 10.1001/journalofethics.2017.19.9.ecas4-1709. Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603. Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Case and Commentary Apr 2019 Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight? Tahir Rahman, MD A form of aripiprazole places unique ethical and clinical demands on mental health professionals. AMA J Ethics. 2019;21(4):E332-336. doi: 10.1001/amajethics.2019.332.
Case and Commentary May 2019 How Should Physicians Respond to Requests for LVAD Removal? Larry A. Allen, MD, MHS Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward. AMA J Ethics. 2019;21(5):E394-400. doi: 10.1001/amajethics.2019.394.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 1 Stephen Corey, MD and Peter Bulova, MD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):373-378. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Policy Forum Dec 2019 How Should Gene Editing Be Managed by Risk Managers? David Sine, D.Bioethics Little claims data exists upon which to make informed decisions about loss control or to draw upon when developing risk mitigation strategies. AMA J Ethics. 2019;21(12):E1059-1064. doi: 10.1001/amajethics.2019.1059.
Case and Commentary Apr 2016 Is Proxy Consent for an Invasive Procedure on a Patient with Intellectual Disabilities Ethically Sufficient? Commentary 2 Sonya Charles, PhD Women with intellectual disabilities should not be sedated for a pap smear without their assent, and the test’s risks and benefits should be weighed. AMA J Ethics. 2016;18(4):379-383. doi: 10.1001/journalofethics.2016.18.4.ecas3-1604.
Case and Commentary Sep 2017 What Does Health Justice Look Like for People Returning from Incarceration? Lisa Puglisi, MD, Joseph P. Calderon, CHW, and Emily A. Wang, MD, MAS Equitable transitions of care for incarcerated patients returning to the community will require physician advocacy and systems-level change. AMA J Ethics. 2017;19(9):903-910. doi: 10.1001/journalofethics.2017.19.9.ecas4-1709.
Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603.
Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559.